Question: what is the latest treatment for multiple myeloma?
Answer: Selinexor (Xpovio) is a new type of multiple myeloma drug called a selective inhibitor of nuclear export (SINE). The FDA approved it for treatment of relapsed or refractory disease in July 2019. It's combined with dexamethasone and is used to treat people who've tried at least four previous therapies.